Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) Equity Ratio (2023 - 2025)

Historic Equity Ratio for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to 0.72.

  • Metagenomi's Equity Ratio rose 83.66% to 0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72, marking a year-over-year increase of 83.66%. This contributed to the annual value of 0.72 for FY2024, which is 29469.41% up from last year.
  • As of Q3 2025, Metagenomi's Equity Ratio stood at 0.72, which was up 83.66% from 0.72 recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Equity Ratio registered a high of 0.72 during Q4 2024, and its lowest value of 0.37 during Q4 2023.
  • Moreover, its 3-year median value for Equity Ratio was 0.71 (2025), whereas its average is 0.57.
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 29469.41% in 2024, then surged by 83.66% in 2025.
  • Quarter analysis of 3 years shows Metagenomi's Equity Ratio stood at 0.37 in 2023, then surged by 294.69% to 0.72 in 2024, then decreased by 0.53% to 0.72 in 2025.
  • Its Equity Ratio was 0.72 in Q3 2025, compared to 0.72 in Q2 2025 and 0.71 in Q1 2025.